by Cleveland Clinic Credit: Journal of Clinical Investigation (2023). DOI: 10.1172/JCI163498 A new prostate cancer therapy in clinical trials could treat patients resistant to treatment through targeting the disease on a molecular level, based on new Cleveland Clinic research. Prostate cancer affects one out of every nine men. Most patients respond to chemical or surgical castration, which stops the body...
